Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Boris Manoury"'
Autor:
Liting Wang, Liang Zhang, Audrey Varin, Zhi-Cheng Jing, Rodolphe Fischmeister, Fabrice Antigny, Frédéric Perros, Véronique Leblais, Boris Manoury
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 15:185
Autor:
Liting Wang, Matthieu Dessillons, Guillaume Pidoux, Rodolphe Fischmeister, Grégoire Vandecasteele, Véronique Leblais, Boris Manoury
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:18-19
Autor:
Liting Wang, Fabien Hubert, Sarah Idres, Milia Belacel-Ouari, Valérie Domergue, Séverine Domenichini, Florence Lefebvre, Delphine Mika, Rodolphe Fischmeister, Véronique Leblais, Boris Manoury
Publikováno v:
European Journal of Pharmacology. 944:175562
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 14:159
Publikováno v:
Pharmacology and Therapeutics
Pharmacology and Therapeutics, Elsevier, 2020, 14, pp.107499. ⟨10.1016/j.pharmthera.2020.107499⟩
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2020, pp.107499. ⟨10.1016/j.pharmthera.2020.107499⟩
Pharmacology and Therapeutics, Elsevier, 2020, 14, pp.107499. ⟨10.1016/j.pharmthera.2020.107499⟩
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2020, pp.107499. ⟨10.1016/j.pharmthera.2020.107499⟩
International audience; Numerous mediators and drugs regulate blood flow or arterial pressure by acting on vascular tone, involving cyclic nucleotide intracellular pathways. These signals lead to regulation of several cellular effectors, including io
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374707297a84953a572b61b0ea8c10f3
https://www.hal.inserm.fr/inserm-02490564
https://www.hal.inserm.fr/inserm-02490564
Autor:
David Montani, Fabrice Antigny, B. Soilih-Abdoulkarim, Frédéric Perros, Boris Manoury, T. Lacoste-Palasset
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 13:189
Introduction Leflunomide (LEF) is an immunomodulator indicated in various diseases including rheumatoid arthritis. Recently, a link between this drug and pulmonary arterial hypertension (PAH) has been suggested (Lacoste-Palasset et al., 2021, Ann Am
Autor:
Boris Manoury, M. Dessillons, Rodolphe Fischmeister, Grégoire Vandecasteele, Véronique Leblais, L. Wang
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 13:192
Introduction Protein kinase A (PKA) is a key enzyme activated by binding of cAMP. PKA induces smooth muscle relaxation and vasodilatation. The PKA-RIα knock-in heterozygous mice, [R368X]/[+] (KI), leading to the generation of a truncated RIα and th
Autor:
Thomas Bertero, Catherine Rucker-Martin, David Montani, Laurent Tesson, Marc Humbert, Fabrice Antigny, Frédéric Perros, Séverine Remy, Véronique Capuano, Barbara Girerd, Ignacio Anegon, Boris Manoury, Christine Péchoux, Olaf Mercier, Mélanie Lambert, Valérie Domergue, Morad K. Nakhleh, Aurélie Hautefort, Angèle Boet
Publikováno v:
Circulation Research
Circulation Research, American Heart Association, 2019, 125 (7), pp.678-695. ⟨10.1161/CIRCRESAHA.119.314793⟩
Circulation Research, 2019, 125 (7), pp.678-695. ⟨10.1161/CIRCRESAHA.119.314793⟩
Circulation Research, American Heart Association, 2019, 125 (7), pp.678-695. ⟨10.1161/CIRCRESAHA.119.314793⟩
Circulation Research, 2019, 125 (7), pp.678-695. ⟨10.1161/CIRCRESAHA.119.314793⟩
Rationale: Pulmonary arterial hypertension is a severe lethal cardiopulmonary disease. Loss of function mutations in KCNK3 (potassium channel subfamily K member 3) gene, which encodes an outward rectifier K + channel, have been identified in pulmonar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2e5a85d626ceb4ed23c4529ed9583c
https://hal.archives-ouvertes.fr/hal-02346635/document
https://hal.archives-ouvertes.fr/hal-02346635/document
Autor:
Mélanie, Lambert, Véronique, Capuano, Angèle, Boet, Laurent, Tesson, Thomas, Bertero, Morad K, Nakhleh, Séverine, Remy, Ignacio, Anegon, Christine, Pechoux, Aurélie, Hautefort, Catherine, Rucker-Martin, Boris, Manoury, Valérie, Domergue, Olaf, Mercier, Barbara, Girerd, David, Montani, Frédéric, Perros, Marc, Humbert, Fabrice, Antigny
Publikováno v:
Circulation research. 125(7)
Pulmonary arterial hypertension is a severe lethal cardiopulmonary disease. Loss of function mutations inWe have demonstrated that KCNK3 dysfunction is common to heritable and nonheritable pulmonary arterial hypertension and to experimental pulmonary
Autor:
Jessica Sabourin, Catherine Rucker-Martin, Marianne Riou, Grégoire Manaud, Thomas Bertero, Ana Maria Gomez, Carmen Brás-Silva, Barbara Girerd, Aurélie Hautefort, Angèle Boet, Rui Adão, Florence Lecerf, Mélanie Lambert, Valérie Domergue, Marc Humbert, Fabrice Antigny, Frédéric Perros, David Montani, P. Mendes-Ferreira, Boris Manoury
Publikováno v:
Circulation
Circulation, 2019, 139 (7), pp.932-948. ⟨10.1161/CIRCULATIONAHA.118.033744⟩
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Circulation, American Heart Association, 2019, 139 (7), pp.932-948. ⟨10.1161/CIRCULATIONAHA.118.033744⟩
Circulation, 2019, 139 (7), pp.932-948. ⟨10.1161/CIRCULATIONAHA.118.033744⟩
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Circulation, American Heart Association, 2019, 139 (7), pp.932-948. ⟨10.1161/CIRCULATIONAHA.118.033744⟩
Background: Monoallelic mutations in the gene encoding bone morphogenetic protein receptor 2 ( Bmpr2 ) are the main genetic risk factor for heritable pulmonary arterial hypertension (PAH) with incomplete penetrance. Several Bmpr2 transgenic mice have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471ef402b0391f9ceecb67c641aa846a
https://hal.science/hal-02346975/document
https://hal.science/hal-02346975/document